XENE
NASDAQ
CA
Xenon Pharmaceuticals Inc. - Common Shares
$56.85
▲ +$0.16
(+0.28%)
Vol 898K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$3.5B
ROE
-46.2%
Margin
-867.3%
D/E
0.00
Beta
0.98
52W
$27–$47
Wall Street Consensus
26 analysts · Apr 202611
Strong Buy
14
Buy
1
Hold
0
Sell
0
Strong Sell
96.2%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-1.21
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-1.21 | — | — |
| Dec 2025 | $-1.22 | $-1.31 | $-0.09 |
| Sep 2025 | $-1.18 | $-1.15 | +$0.03 |
| Jun 2025 | $-1.01 | $-1.07 | $-0.06 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -38.5% | -38.5% | -38.5% | -38.5% | -46.2% | -46.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -867.3% | -867.3% | -867.3% | -867.3% | -867.3% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 15.14 | 15.14 | 15.14 | 15.14 | 12.52 | 12.52 |
Key Ratios
ROA (TTM)
-43.4%
P/S (TTM)
461.80
P/B
4.0
EPS (TTM)
$-3.88
CF/Share
$-2.61
52W High
$46.60
52W Low
$26.74
$26.74
52-Week Range
$46.60
How does XENE compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
XENE valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
461.8
▲
3494%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
4.0
▲
61%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
XENE profitability vs Biotechnology peers
ROE
-46.2%
▲
31%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-867.3%
▼
202%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-43.4%
▲
7%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
XENE financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
12.5
▲
182%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.0
▲
1%
above
peers
(1.0)
vs Peers
vs Industry
Less volatile
XENE fundamentals radar
XENE
Peer median
Industry
XENE profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
XENE vs peers: key metrics
Latest News
No related news yet